Metraipolis › archive › dc_2f0926795367

Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1-Year Comparative Study — Europe PMC PMID:40966463

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40966463
DOI
10.1002/clc.70192
License (as archived)
solo-consultazione
Archived
2026-11-10T04:55:54.356Z
SHA-256 of the archived text
343c0a470db44623cc5759bc92df6e181a7f6ba29e6176c50db11b7d6231187c
Stable URL of this page
https://metraipolis.com/documento/dc_2f0926795367

How to cite

Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1-Year Comparative Study — Europe PMC PMID:40966463 — Europe PMC (en), https://europepmc.org/article/MED/40966463 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f0926795367 (Metraipolis archive dc_2f0926795367, sha256 343c0a470db44623cc5759bc92df6e181a7f6ba29e6176c50db11b7d6231187c)
BibTeX
@misc{dc2f0926795367,
  title = {Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1-Year Comparative Study — Europe PMC PMID:40966463},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40966463},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f0926795367; sha256 343c0a470db44623cc5759bc92df6e181a7f6ba29e6176c50db11b7d6231187c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40966463. Agents can read the archived copy with the MCP tool read_document.